Eurobio Scientific (STU:E8TN) Marketable Securities: €0.3 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:E8TN Eurobio Scientific STU:E8TN
69 GF Score
Price €19.20
GF Value €25.29
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eurobio Scientific Marketable Securities?

Eurobio Scientific STU:E8TN +0.79% 69 Marketable Securities is €0.3 Mil as of Dec. 2025. GuruFocus rates STU:E8TN with a GF Score™ of 69/100 and a GF Value™ of €25.29 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Eurobio Scientific's Marketable Securities for the quarter that ended in Dec. 2025 was €0.3 Mil.

Eurobio Scientific's annual Marketable Securities declined from Dec. 2023 (€39.7 Mil) to Dec. 2024 (€1.3 Mil) and declined from Dec. 2024 (€1.3 Mil) to Dec. 2025 (€0.3 Mil).

Eurobio Scientific  (STU:E8TN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Eurobio Scientific Marketable Securities Related Terms

Eurobio Scientific Marketable Securities Historical Data

* Premium members only.

The historical data trend for Eurobio Scientific's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurobio Scientific Marketable Securities Chart

Eurobio Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.47 38.44 39.73 1.29 0.35

Eurobio Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.73 41.47 1.29 0.39 0.35
STU:E8TN
69GF Score
Eurobio Scientific STU:E8TN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurobio Scientific Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.3 Mil mean?
Eurobio Scientific (STU:E8TN) has a Marketable Securities of €0.3 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Eurobio Scientific and its competitors.
Is Eurobio Scientific's Marketable Securities too high?
Eurobio Scientific's current Marketable Securities is €0.3 Mil. Overall, Eurobio Scientific has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eurobio Scientific's Marketable Securities compare to ABT and SYK?
Eurobio Scientific's Marketable Securities of €0.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Eurobio Scientific and its competitors. Eurobio Scientific's current Marketable Securities is €0.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurobio Scientific stock overvalued right now?
Based on GuruFocus' analysis, Eurobio Scientific (STU:E8TN) is currently considered Modestly Undervalued. The stock's GF Value™ is €25.29, compared to a current price of €19.20 — trading 24.1% below its estimated fair value. The current Marketable Securities is €0.3 Mil. Eurobio Scientific's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Eurobio Scientific (STU:E8TN), the current Marketable Securities is €0.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurobio Scientific (STU:E8TN) Overvalued in 2026?

Based on GuruFocus' analysis, Eurobio Scientific stock appears to be undervalued. The current stock price of €19.20 is trading 24.1% below its estimated GF Value™ of €25.29. GuruFocus considers Eurobio Scientific to be Modestly Undervalued.

Key valuation signals for STU:E8TN:

  • Marketable Securities: €0.3 Mil
  • GF Value™: €25.29 vs. price of €19.20 (24.1% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the STU:E8TN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurobio Scientific Business Description

Other Exchanges ALERS:France
Address 63-65 Boulevard Massena, Paris, FRA, 75013
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
69GF Score

Get the complete analysis for STU:E8TN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.20
Price
€25.29
GF Value